A detailed history of Atlas Brown,Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Atlas Brown,Inc. holds 4,283 shares of NVO stock, worth $509,976. This represents 0.22% of its overall portfolio holdings.

Number of Shares
4,283
Previous 3,823 12.03%
Holding current value
$509,976
Previous $490,000 24.69%
% of portfolio
0.22%
Previous 0.18%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$122.71 - $146.91 $56,446 - $67,578
460 Added 12.03%
4,283 $611,000
Q1 2024

Apr 08, 2024

BUY
$102.11 - $135.92 $9,700 - $12,912
95 Added 2.55%
3,823 $490,000
Q3 2023

Oct 17, 2023

BUY
$90.94 - $199.54 $169,512 - $371,942
1,864 Added 100.0%
3,728 $339,000
Q1 2023

Apr 21, 2023

BUY
$132.34 - $159.14 $529 - $636
4 Added 0.22%
1,864 $296,000
Q4 2022

Jan 05, 2023

BUY
$102.55 - $135.33 $190,743 - $251,713
1,860 New
1,860 $0
Q4 2021

Jan 18, 2022

BUY
$95.88 - $117.08 $178,336 - $217,768
1,860 New
1,860 $208,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $269B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Atlas Brown,Inc. Portfolio

Follow Atlas Brown,Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Brown,Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atlas Brown,Inc. with notifications on news.